Cargando…
Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial
We conducted a double-blind, randomized trial of 134 outpatients with polymerase chain reaction-confirmed influenza to assess the effects of oseltamivir initiated 48–119 hours after illness onset. Oseltamivir treatment did not reduce illness duration, severity, or duration of virus detection. Howeve...
Autores principales: | McLean, Huong Q., Belongia, Edward A., Kieke, Burney A., Meece, Jennifer K., Fry, Alicia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525010/ https://www.ncbi.nlm.nih.gov/pubmed/26258157 http://dx.doi.org/10.1093/ofid/ofv100 |
Ejemplares similares
-
Clinical and virologic outcomes in patients with oseltamivir‐resistant seasonal influenza A (H1N1) infections: results from a clinical trial
por: Dharan, Nila J., et al.
Publicado: (2011) -
A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting
por: VanWormer, Jeffrey J, et al.
Publicado: (2014) -
Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type
por: McLean, Huong Q., et al.
Publicado: (2015) -
School absenteeism among school‐aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012‐2013 through 2014‐2015
por: McLean, Huong Q., et al.
Publicado: (2017) -
Prediction of serious RSV‐related outcomes in older adults with outpatient RSV respiratory illness during 12 consecutive seasons
por: Kieke, Burney A., et al.
Publicado: (2020)